Update on the Role of Imaging in Clinical Staging and Restaging of Renal Cell Carcinoma Based on the AJCC 8th Edition, From the AJR Special Series on Cancer …
This article reviews the essential role of imaging in clinical staging and restaging of renal
cell carcinoma (RCC). To completely characterize and stage an indeterminate renal mass …
cell carcinoma (RCC). To completely characterize and stage an indeterminate renal mass …
Biomarkers for the detection and surveillance of renal cancer
JI Nolazco, SJC Soerensen, BI Chung - Urologic Clinics, 2023 - urologic.theclinics.com
Renal cell carcinoma (RCC) is one of the most commonly diagnosed cancers in the United
States. It accounts for approximately 4.0% of new cancers and 2.3% of cancer-specific …
States. It accounts for approximately 4.0% of new cancers and 2.3% of cancer-specific …
Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC: CPT1A inhibits ccRCC cell proliferation via …
H Yang, H Zhao, Z Ren, X Yi, Q Zhang… - Acta Biochimica et …, 2021 - pmc.ncbi.nlm.nih.gov
Clear cell renal carcinoma (ccRCC) is histologically defined by its cytoplasmic lipid deposits.
Lipid metabolism disorder largely increases the risk of ccRCC. In this study, we aimed to …
Lipid metabolism disorder largely increases the risk of ccRCC. In this study, we aimed to …
[HTML][HTML] Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene
B Xu, WJ Zhu, YJ Peng, SD Cheng - Translational cancer research, 2021 - ncbi.nlm.nih.gov
Background To explore the possible mechanism by which curcumin reverses the sunitinib
resistance in clear cell renal cell carcinoma (ccRCC). Methods A sunitinib-resistant ccRCC …
resistance in clear cell renal cell carcinoma (ccRCC). Methods A sunitinib-resistant ccRCC …
MRI radiomics-based nomogram for individualised prediction of synchronous distant metastasis in patients with clear cell renal cell carcinoma
X Bai, Q Huang, P Zuo, X Zhang, J Yuan, X Zhang… - European …, 2021 - Springer
Objective To evaluate the performance of a multiparametric MRI radiomics-based
nomogram for the individualised prediction of synchronous distant metastasis (SDM) in …
nomogram for the individualised prediction of synchronous distant metastasis (SDM) in …
Practical identifiability analysis of a mechanistic model for the time to distant metastatic relapse and its application to renal cell carcinoma
A Álvarez-Arenas, W Souleyreau… - PLoS Computational …, 2022 - journals.plos.org
Distant metastasis-free survival (DMFS) curves are widely used in oncology. They are
classically analyzed using the Kaplan-Meier estimator or agnostic statistical models from …
classically analyzed using the Kaplan-Meier estimator or agnostic statistical models from …
The establishment of kidney cancer organoid line in drug testing
RTH Tse, CYP Wong, X Ding, CKL Cheng… - Cancer …, 2024 - Wiley Online Library
Introduction Kidney cancer is a common urological malignancy worldwide with an
increasing incidence in recent years. Among all subtypes, renal cell carcinoma (RCC) …
increasing incidence in recent years. Among all subtypes, renal cell carcinoma (RCC) …
Use of dual-energy CT for renal mass assessment
S Thiravit, C Brunnquell, LM Cai, M Flemon… - European Radiology, 2021 - Springer
Although dual-energy CT (DECT) may prove useful in a variety of abdominal imaging tasks,
renal mass evaluation represents the area where this technology can be most impactful in …
renal mass evaluation represents the area where this technology can be most impactful in …
LncRNA-SERB promotes vasculogenic mimicry (VM) formation and tumor metastasis in renal cell carcinoma
S Tang, F Chen, J Zhang, F Chang, Z Lv, K Li… - Journal of Biological …, 2024 - ASBMB
A growing body of evidence shows that vasculogenic mimicry (VM) is closely related to the
invasion and metastasis of many tumor cells. Although the estrogen receptor (ER) can …
invasion and metastasis of many tumor cells. Although the estrogen receptor (ER) can …
KIDNEY-PAGER: analysis of circulating tumor DNA as a biomarker in renal cancer–an observational trial. Study protocol
L Iisager, J Ahrenfeldt, AK Keller, TK Nielsen… - Acta …, 2023 - pmc.ncbi.nlm.nih.gov
Background Management of localized renal cell carcinoma (RCC) is challenged by
inaccurate methods to assess the risk of recurrence and deferred detection of relapse and …
inaccurate methods to assess the risk of recurrence and deferred detection of relapse and …